Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines KOS Q1 2026 Earnings EPS Miss Weighs on Shares as Operating Environment Challenges Persist PEW Q1 2026 Earnings EPS Surprise Beats Estimates by 505 Stock Falls 214 FSEA Q3 2024 Earnings Modest Profit Amid Narrowing Margins VICR Q1 2026 Earnings EPS Surges Past Estimates with 1983 Surprise Camden National Corporation CAC Q1 2026 Earnings EPS Beats Estimates Amid Net Interest Margin Pressure Stock Edges Lower